Company Dossier · Health Care
Tenet Healthcare
- Russell 1000
- MidCap 400
What Tenet Healthcare is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.
Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →
The latest read
Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.
- Revenue over the four quarters to June 30, 2026: $21.8 billion, up 5.4% from a year earlier.SEC EDGAR filings (XBRL)
- Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: $3.02 billion, up 95% from a year earlier.SEC EDGAR filings (XBRL)
- Capital expenditure over the four quarters to June 30, 2026: $0.99 billion, up 8.8% from a year earlier.SEC EDGAR filings (XBRL)
- Share buybacks in the fiscal year to December 31, 2025: $1.39 billion.SEC EDGAR filings (10-K)
- Long-term debt issued in the fiscal year to December 31, 2025: $2.28 billion.SEC EDGAR filings (10-K)
- Latest earnings call or results release (July 24, 2026): sentiment 0.70 on a −1 to +1 scale (confident, opportunity-framed), confidence 0.80 of 1.Palanor Discourse
- Latest annual report (filed February 17, 2026): 0 risk factors added, 0 removed.Risk Factor Changes (10-K Item 1A)
- Insiders were net sellers in Q3 2026: $50.0 million on the open market.SEC Form 4
- 681 institutional managers reported a position at June 30, 2026 (−14 on the quarter before).SEC Form 13F
- H-1B filings certified in Q2 2026: 26 (21 a year earlier).U.S. Department of Labor (OFLC)
Company Posture
How Company Posture is measured →Company Posture covers S&P 500 companies.
Credit
How these are built →No bond term sheets or tagged debt on file for Tenet Healthcare yet.
Charts
Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.
Cash flow
Capital returned and raised
What the company says
Hiring and ownership
Filings and records
The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.
- Oct 20, 2026LobbyingLobbying report (TENET HEALTHCARE CORPORATION)third_quarter 2026 · $1.2 million
- Oct 20, 2026LobbyingLobbying report (CARMEN GROUP INCORPORATED)third_quarter 2026 · $0.2 million
- Oct 16, 2026LobbyingLobbying report (BROWNSTEIN HYATT FARBER SCHRECK, LLP)third_quarter 2026 · $0.1 million
- Oct 15, 2026LobbyingLobbying report (HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP))third_quarter 2026 · $0.1 million
- Sep 22, 20268-KMaterial agreement signedItem 1.01
- Jul 20, 2026LobbyingLobbying report (CARMEN GROUP INCORPORATED)second_quarter 2026 · $0.2 million
- Jul 20, 2026LobbyingLobbying report (TENET HEALTHCARE CORPORATION)second_quarter 2026 · $1.2 million
- Jul 15, 2026LobbyingLobbying report (BROWNSTEIN HYATT FARBER SCHRECK, LLP)second_quarter 2026 · $0.1 million
- Jun 30, 2026Private creditLoans held by business development companies (Tenet Healthcare Corp)$2.7 million at cost
- May 29, 20268-KShareholder vote resultsItem 5.07
- Apr 20, 2026LobbyingLobbying report (TENET HEALTHCARE CORPORATION)first_quarter 2026 · $1.2 million
- Apr 10, 20268-KDirector or officer changeItem 5.02
- Mar 30, 20268-KDirector or officer changeItem 5.02
- Feb 17, 202610-KAnnual report (10-K)0 risk factors added, 0 removed
- Nov 24, 20258-KDirector or officer changeItem 5.02
- Nov 18, 20258-KMaterial agreement signedItem 1.01
- Nov 5, 20258-KMaterial agreement signedItem 1.01
- Jun 5, 20258-KDirector or officer changeItem 5.02
- May 27, 20258-KShareholder vote resultsItem 5.07
- Feb 18, 202510-KAnnual report (10-K)2 risk factors added, 0 removed
- Jan 24, 20258-KDirector or officer changeItem 5.02
- Dec 10, 2024Risk event
- Feb 16, 202410-KAnnual report (10-K)2 risk factors added, 2 removed
Peers
Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.
| Company | Revenue | Free cash flow | Through |
|---|---|---|---|
| Universal Health Services UHS | $18.1B | $0.8B | Jun 30, 2026 |
| HCA Healthcare HCA | $76.4B | $7.9B | Mar 31, 2026 |
| Encompass Health EHC | $6.2B | $0.4B | Jun 30, 2026 |
| Becton Dickinson BDX | $22.5B | $2.7B | Jun 30, 2026 |
| Boston Scientific BSX | $21.0B | $3.6B | Jun 30, 2026 |
| GE HealthCare GEHC | $21.0B | — | Mar 31, 2026 |
| Danaher Corp. DHR | $25.1B | $5.5B | Jun 26, 2026 |
| Stryker Corporation SYK | $25.8B | $4.7B | Jun 30, 2026 |